T1	Limited_variation	13 37	BCR-ABL kinase mutations
T2	Disease	59 96	chronic myelogenous leukemia patients
T3	Phenotype	113 134	ogenetic remission on
T4	Chemical	135 162	imatinib mesylate treatment
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T2	Arg2:T1
R5	isAssociatedWith	Arg1:T2	Arg2:T3
R6	isAssociatedWith	Arg1:T2	Arg2:T4
R7	isAssociatedWith	Arg1:T3	Arg2:T1
R8	treats	Arg1:T3	Arg2:T2
R9	influences	Arg1:T3	Arg2:T4
R10	treats	Arg1:T4	Arg2:T1
R11	treats	Arg1:T4	Arg2:T2
R12	treats	Arg1:T4	Arg2:T3
